In this issue of Clinics in Laboratory Medicine, guest editor Dr. Alexa J. Siddon brings her considerable expertise to the topic of Myelodysplastic Syndromes. Top experts in the field discuss the various aspects of rare myelodysplastic syndromes and its treatments, detection, and characteristics. Topics include molecular changes in myelodysplastic syndromes; MDS with mutated SF3B1; myeloid neoplasms with mutated TP53; mimics of myelodysplastic syndromes; myeloid neoplasms with germline predisposition; and more.
Contains 12 practice-oriented topics including premalignant clonal hematopoiesis (CHIP and CCUS); morphologic characteristics of MDS; acute leukemia arising from MDS; treatment considerations of MDS for pathologists; and more.
Provides in-depth clinical reviews on myelodysplastic syndromes, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms - p. 521 9. Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes - p. 549 10. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance) - p. 565 11. Morphologic Characteristics of Myelodysplastic Syndromes - p. 577 12. Significance of SF3B1 Mutations in Myeloid Neoplasms - p. 597 13. Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53 - p. 607 14. Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications - p. 615 15. Childhood Myelodysplastic Syndrome - p. 639 16. Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes - p. 657 17. Transfusion Support of Patients with Myelodysplastic Syndromes - p. 669 18. Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists - p. 685
In this issue of Clinics in Laboratory Medicine, guest editor Dr. Alexa J. Siddon brings her considerable expertise to the topic of Myelodysplastic Syndromes. Top experts in the field discuss the various aspects of rare myelodysplastic syndromes and its treatments, detection, and characteristics. Topics include molecular changes in myelodysplastic syndromes; MDS with mutated SF3B1; myeloid neoplasms with mutated TP53; mimics of myelodysplastic syndromes; myeloid neoplasms with germline predisposition; and more.
Contains 12 practice-oriented topics including premalignant clonal hematopoiesis (CHIP and CCUS); morphologic characteristics of MDS; acute leukemia arising from MDS; treatment considerations of MDS for pathologists; and more.
Provides in-depth clinical reviews on myelodysplastic syndromes, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms - p. 521 9. Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes - p. 549 10. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance) - p. 565 11. Morphologic Characteristics of Myelodysplastic Syndromes - p. 577 12. Significance of SF3B1 Mutations in Myeloid Neoplasms - p. 597 13. Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53 - p. 607 14. Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications - p. 615 15. Childhood Myelodysplastic Syndrome - p. 639 16. Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes - p. 657 17. Transfusion Support of Patients with Myelodysplastic Syndromes - p. 669 18. Treatment Considerations of Myelodysplastic Syndromes/Neoplasms for Pathologists - p. 685
